118 related articles for article (PubMed ID: 7945983)
21. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
Baum T; Becker FT; Sybertz EJ
Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
[TBL] [Abstract][Full Text] [Related]
22. Chronic low-dose treatment with enalapril induced cardiac regression of left ventricular hypertrophy.
Makino N; Sugano M; Hata T; Taguchi S; Yanaga T
Mol Cell Biochem; 1996; 163-164():239-45. PubMed ID: 8974063
[TBL] [Abstract][Full Text] [Related]
23. Distribution of Fos-immunoreactivity in rat brain following a dipsogenic dose of captopril and effects of angiotensin receptor blockade.
McKinley MJ; Colvill LM; Giles ME; Oldfield BJ
Brain Res; 1997 Jan; 747(1):43-51. PubMed ID: 9042526
[TBL] [Abstract][Full Text] [Related]
24. Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue.
Barnes NM; Costall B; Egli P; Horovitz ZP; Ironside JW; Naylor RJ; Williams TJ
Neuropharmacology; 1991 Aug; 30(8):907-14. PubMed ID: 1664073
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin-converting enzyme inhibition, angiotensin, and cognition.
Barnes JM; Barnes NM; Costall B; Coughlan J; Kelly ME; Naylor RJ; Tomkins DM; Williams TJ
J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S63-71. PubMed ID: 1382167
[TBL] [Abstract][Full Text] [Related]
26. Action of angiotensin converting enzyme inhibitors in rat brain: interaction with isoproterenol assessed by Fos immunocytochemistry.
Rowland NE; Fregly MJ; Li BH; Smith GC
Brain Res; 1994 Aug; 654(1):34-40. PubMed ID: 7982096
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of the action of angiotensin-converting enzyme inhibitors on agonist-induced Ca2+ influx.
Zhu Z; Tepel M; Neusser M; Zidek W
J Vasc Res; 1994; 31(5):265-70. PubMed ID: 7522595
[TBL] [Abstract][Full Text] [Related]
28. Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models.
Tokioka T; Shibasaki M; Fujimori A; Matsuda-Satoh Y; Uchida W; Inagaki O; Yanagisawa I
Biol Pharm Bull; 2000 Feb; 23(2):174-81. PubMed ID: 10706380
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the effects of angiotensin-converting enzyme inhibitors with bradykinin, angiotensin II and their specific antagonists on concanavalin A-induced proliferation of mouse T-lymphocytes.
Yeung JH
Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):163-72. PubMed ID: 8046949
[TBL] [Abstract][Full Text] [Related]
30. Attenuation of alcohol intake by a serotonin uptake inhibitor: evidence for mediation through the renin-angiotensin system.
Grupp LA; Perlanski E; Stewart RB
Pharmacol Biochem Behav; 1988 Aug; 30(4):823-7. PubMed ID: 2852370
[TBL] [Abstract][Full Text] [Related]
31. No evidence for involvement of angiotensin II in spatial learning in water maze in rats.
Chalas A; Conway EL
Behav Brain Res; 1996 Nov; 81(1-2):199-205. PubMed ID: 8950017
[TBL] [Abstract][Full Text] [Related]
32. Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats.
Abd El-Aziz MA; Othman AI; Amer M; El-Missiry MA
J Appl Toxicol; 2001; 21(6):469-73. PubMed ID: 11746193
[TBL] [Abstract][Full Text] [Related]
33. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats.
Ruzicka M; Skarda V; Leenen FH
Circulation; 1995 Dec; 92(12):3568-73. PubMed ID: 8521580
[TBL] [Abstract][Full Text] [Related]
34. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
Costerousse O; Allegrini J; Clozel JP; Ménard J; Alhenc-Gelas F
J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881
[TBL] [Abstract][Full Text] [Related]
36. The involvement of the renin-angiotensin system in the regulation of cell proliferation in the rat endometrium.
Pawlikowski M; Meleń-Mucha G; Mucha S
Cell Mol Life Sci; 1999 Mar; 55(3):506-10. PubMed ID: 10228564
[TBL] [Abstract][Full Text] [Related]
37. The ACE inhibitors enalapril and captopril modulate cytokine responses in Balb/c and C57Bl/6 normal mice and increase CD4(+)CD103(+)CD25(negative) splenic T cell numbers.
Albuquerque D; Nihei J; Cardillo F; Singh R
Cell Immunol; 2010; 260(2):92-7. PubMed ID: 19854435
[TBL] [Abstract][Full Text] [Related]
38. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Atlas SA; Case DB; Yu ZY; Laragh JH
Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
[TBL] [Abstract][Full Text] [Related]
39. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors.
Liao S; Miralles M; Kelley BJ; Curci JA; Borhani M; Thompson RW
J Vasc Surg; 2001 May; 33(5):1057-64. PubMed ID: 11331849
[TBL] [Abstract][Full Text] [Related]
40. The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat.
Banks RJ; Mozley L; Dourish CT
Neuroscience; 1994 Feb; 58(4):799-805. PubMed ID: 8190257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
